ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
12/18/2024
Back to search
Official data from USPTO
TEROCIN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
12/18/2024
Trademark type
Combined
Nice classes
5
Filing date
11/14/2013
Registration date
10/14/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/03/2024
Last transaction
06/03/2024
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
11/01/2011
First use in commerce
11/01/2011
Drawing code
3
Owner type
16
Owner location
LOS ANGELES, CA, US
Examiner
GALAN,MATTHEW
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the term "TEROCIN" in stylized green font. Above the letter "I" is a single green leaf blowing north east at roughly a 45 degree angle. Within the leaf there is a single white line in the middle of the leaf following the same direction of the leaf. Just within the borders of the leaf there are thin light green lines.
Holders and representatives
Holders
S.A.A.A INVESTMENTS, LLC.
Alexso, Inc.
Alexso, Inc.
Representatives
S.A.A.A INVESTMENTS, LLC.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Analgesic and muscle relaxant pharmaceutical preparations; Balms for pharmaceutical purposes; Chemical preparations for pharmaceutical or medical purposesfor reduction of pain and inflammation; Gelscreams and solutions for dermatological use; Herbal topical creamsgelssalvessprayspowderbalmsliniment and ointments for the relief of aches and pain; Homeopathic pharmaceuticals for use in the treatment of pain and inflammation; Menthol for pharmaceutical purposes; Pharmaceutical preparations for the treatment and prevention of pain and inflammation; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorderssports related injuriesfor knee cartilage regeneration; Pharmaceutical preparations for reduction of pain and inflammation; Preparation for the relief of pain
Publications
History of USPTO decisions and trademark events.
42 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/18/2024
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/03/2024
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
06/03/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/03/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/17/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
05/01/2024
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
04/30/2024
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
04/24/2024
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
04/23/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/23/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/27/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
12/20/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/14/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/21/2019
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/21/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/21/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/15/2019
E815
TEAS SECTION 8 & 15 RECEIVED
10/15/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/14/2019
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
06/12/2015
PLGL
ASSIGNED TO PARALEGAL
06/12/2015
ES7R
TEAS SECTION 7 REQUEST RECEIVED
06/11/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/11/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/04/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
10/14/2014
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
09/05/2014
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
05/13/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/22/2014
PUBO
PUBLISHED FOR OPPOSITION
04/22/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/02/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/20/2014
ALIE
ASSIGNED TO LIE
03/20/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/05/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
03/05/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/05/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
03/05/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/05/2014
DOCK
ASSIGNED TO EXAMINER
03/01/2014
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/28/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/27/2013
NWAP
NEW APPLICATION ENTERED
11/18/2013
Continuous trademark protection
Get notified about every new filing that threatens TEROCIN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.